摘要
目的:建立LC-MS测定人血浆中右酮洛芬浓度的方法。方法:待测血浆样品经甲醇沉淀后,用LC-MS法进行检测,以非布司他为内标。色谱柱为Inspire C18(150 mm×2.1 mm,5μm),流动相为5 mmol.L-1醋酸铵溶液(0.05%乙酸)-甲醇(32∶68),流速为0.35 mL.min-1;质谱采用电喷雾离子化(ESI)方式和选择性离子检测(SIM)模式,检测离子为负离子。结果:本方法线性范围为0.01~20μg.mL-1,最低定量浓度0.01μg.mL-1,准确度、精密度以及稳定性均符合有关要求。结论:该方法简便、准确,灵敏度高,专属性强,适用于人血浆中右酮洛芬浓度的测定。
Objective: To establish a liquid chromatography-mass spectrometry(LC-MS) method for determination of dexketoprofen in human plasma.Methods: The plasma samples were precipitated by methanol.The drug and an internal standard(febuxostat) were separated on a Inspire C18(150 mm×2.1 mm,5 μm) column by Agilent LC-MS with 5 mmol·L-1 ammonium acetate(0.05% acetic acid)-methanol(32∶68) as the mobile phase at a flow rate of 0.35 mL·min-1.The detection was carried out by means of electrospray ionization mass spectrometry in negative ion mode.Selective ion(SIM) mode was used.Results: The assay had the calibration range from 0.01 to 20 μg·mL-1 and the lower limit of quantification(LLOQ) was 0.01 μg·mL-1 for dexketoprofen.The accuracy,precision(intra-day and inter-day),sensitivity,specificity and stability(ambient temperature,freeze/thaw,freeze storage) of the method fulfilled the analytical validation criteria of the guideline.Conclusion: The method is simple,accurate,sensitive and specific for determination of dexketoprofen in human plasma.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2013年第1期75-78,共4页
Chinese Journal of New Drugs
基金
国家"重大新药创制"科技重大专项(2011ZXJ09202-13)